Créquit, P., Yavchitz, A., Trinquart, L., Ravaud, P., & Cadranel, J. (2018). Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second‐line treatment for non–small‐cell lung cancer wild‐type or unknown status for EGFR. Cochrane Database Syst Rev.
শিকাগো স্টাইলে সাইটেশনCréquit, Perrine, Amelie Yavchitz, Ludovic Trinquart, Philippe Ravaud, এবং Jacques Cadranel. "Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Versus Single Agent Chemotherapy As Second‐line Treatment for Non–small‐cell Lung Cancer Wild‐type or Unknown Status for EGFR." Cochrane Database Syst Rev 2018.
এমএলএ সাইটেশনCréquit, Perrine, et al. "Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Versus Single Agent Chemotherapy As Second‐line Treatment for Non–small‐cell Lung Cancer Wild‐type or Unknown Status for EGFR." Cochrane Database Syst Rev 2018.